Janin A - Search Results

1

Nf2 gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mouse.

Kalamarides M, Niwa-Kawakita M, Leblois H, Abramowski V, Perricaudet M, Janin A, Thomas G, Gutmann DH, Giovannini M. Kalamarides M, et al. Among authors: janin a. Genes Dev. 2002 May 1;16(9):1060-5. doi: 10.1101/gad.226302. Genes Dev. 2002. PMID: 12000789 Free PMC article.

2

Hemizygosity of Nf2 is associated with increased susceptibility to asbestos-induced peritoneal tumours.

Fleury-Feith J, Lecomte C, Renier A, Matrat M, Kheuang L, Abramowski V, Levy F, Janin A, Giovannini M, Jaurand MC. Fleury-Feith J, et al. Among authors: janin a. Oncogene. 2003 Jun 12;22(24):3799-805. doi: 10.1038/sj.onc.1206593. Oncogene. 2003. PMID: 12802287

3

TEL-JAK2 transgenic mice develop T-cell leukemia.

Carron C, Cormier F, Janin A, Lacronique V, Giovannini M, Daniel MT, Bernard O, Ghysdael J. Carron C, et al. Among authors: janin a. Blood. 2000 Jun 15;95(12):3891-9. Blood. 2000. PMID: 10845925 Free article.

4

The soluble fragment of VE-cadherin inhibits angiogenesis by reducing endothelial cell proliferation and tube capillary formation.

Li H, Shi X, Liu J, Hu C, Zhang X, Liu H, Jin J, Opolon P, Vannier JP, Perricaudet M, Janin A, Soria C, Lu H. Li H, et al. Among authors: janin a. Cancer Gene Ther. 2010 Oct;17(10):700-7. doi: 10.1038/cgt.2010.26. Epub 2010 Jun 18. Cancer Gene Ther. 2010. PMID: 20559333

5

Clinico-pathological features and somatic gene alterations in refractory ceramic fibre-induced murine mesothelioma reveal mineral fibre-induced mesothelioma identities.

Andujar P, Lecomte C, Renier A, Fleury-Feith J, Kheuang L, Daubriac J, Janin A, Jaurand MC. Andujar P, et al. Among authors: janin a. Carcinogenesis. 2007 Jul;28(7):1599-605. doi: 10.1093/carcin/bgm023. Epub 2007 Feb 1. Carcinogenesis. 2007. PMID: 17272307 Free PMC article.

6

Meningioma in long-term survivors after allogeneic bone marrow transplantation.

Meignin V, Gluckman E, Gambaraelli D, Devergie A, Ramee MP, Janin A, Socié G. Meignin V, et al. Among authors: janin a. Bone Marrow Transplant. 1998 Oct;22(7):723-4. doi: 10.1038/sj.bmt.1701407. Bone Marrow Transplant. 1998. PMID: 9818703

7

Tracking sub-clonal TP53 mutated tumor cells in human metastatic renal cell carcinoma.

Bousquet G, El Bouchtaoui M, Leboeuf C, Battistella M, Varna M, Ferreira I, Plassa LF, Hamdan D, Bertheau P, Feugeas JP, Damotte D, Janin A. Bousquet G, et al. Among authors: janin a. Oncotarget. 2015 Aug 7;6(22):19279-89. doi: 10.18632/oncotarget.4220. Oncotarget. 2015. PMID: 26002555 Free PMC article.

8

TP53 status and response to chemotherapy in breast cancer.

Bertheau P, Espié M, Turpin E, Lehmann J, Plassa LF, Varna M, Janin A, de Thé H. Bertheau P, et al. Among authors: janin a. Pathobiology. 2008;75(2):132-9. doi: 10.1159/000123851. Epub 2008 Jun 10. Pathobiology. 2008. PMID: 18544968 Review.

9

Human skin carcinoma arising from kidney transplant-derived tumor cells.

Verneuil L, Varna M, Ratajczak P, Leboeuf C, Plassa LF, Elbouchtaoui M, Schneider P, Sandid W, Lebbé C, Peraldi MN, Sigaux F, de Thé H, Janin A. Verneuil L, et al. Among authors: janin a. J Clin Invest. 2013 Sep;123(9):3797-801. doi: 10.1172/JCI66721. Epub 2013 Aug 27. J Clin Invest. 2013. PMID: 23979160 Free PMC article.

10

Increased apoptosis is linked to severe acute GVHD in patients with Fanconi anemia.

Wang L, Romero M, Ratajczak P, Lebœuf C, Belhadj S, Peffault de Latour R, Zhao WL, Socié G, Janin A. Wang L, et al. Among authors: janin a. Bone Marrow Transplant. 2013 Jun;48(6):849-53. doi: 10.1038/bmt.2012.237. Epub 2012 Dec 10. Bone Marrow Transplant. 2013. PMID: 23222379 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

519 results

Search Page

Filters